Global Osteoarthritis Therapeutics Market Analysis to 2029 – Featuring Sanofi, Horizon Therapeutics, Johnson & Johnson and Eli Lilly Among Others – ResearchAndMarkets.com
Global Osteoarthritis Therapeutics Market Analysis to 2029 – Featuring Sanofi, Horizon Therapeutics, Johnson & Johnson and Eli Lilly Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Osteoarthritis Therapeutics Market Analysis by Anatomy, by Drug Type, by Route of Administration, by Purchasing Pattern by Distribution Channel and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.
The osteoarthritis therapeutics market size is estimated to be USD 8.5 billion in 2021 and is expected to witness a CAGR of 10.11% during the forecast period 2022-2029.
The increased use of pain relievers and growing frequency of osteoarthritis are some of the key drivers for the market growth. Additionally, escalating sports injuries is projected to drive the market growth in near future.
However, incidence of negative cardiovascular events related with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) and presence of alternatives are expected to restrain the market growth.
Companies Mentioned
- Sanofi (France)
- Horizon Therapeutics PLC (Ireland)
- Johnson & Johnson (US)
- GlaxoSmithKline PLC (UK)
- Bayer AG (Germany)
- Abbott (US)
- Pfizer Inc. (US)
- Eli Lilly (US)
- Anika Therapeutics Inc. (US)
- Novartis AG (Switzerland)
- Ferring Pharmaceuticals (Switzerland)
- Bioventus (US)
- Zimmer Biomet Holdings Inc. (US)
- Fidia Farmaceutici s.p.a. (Italy)
- Flexion Therapeutics Inc. (US)
- Pharmed Limited (India)
- Virchow Biotech (India)
- Kitov Pharmaceuticals Ltd. (Israel)
- Assertio Therapeutics Inc. (US)
- Atnahs (UK)
- Almatica Pharma LLC (US)
- OrthogenRx (US)
- LABRHA (France)
- Hanmi Pharm. Co. Ltd. (Korea)
- Laboratorio Reig Jofre (Spain)
Market Segmentation:
By Anatomy (Revenue, USD Billion)
- Hip Osteoarthritis
- Knee Osteoarthritis
- Small Joint Osteoarthritis
- Hand Osteoarthritis
By Drug Type (Revenue, USD Billion)
- Analgesics
- Corticosteroids
- Viscosupplementation Agents
- Nonsteroidal Anti-inflammatory Drugs
By Route of Administration (Revenue, USD Billion)
- Topical Route
- Oral Route
- Parenteral Route
By Purchasing Pattern (Revenue, USD Billion)
- Prescription Drugs
- Over-the-Counter Drugs
By Distribution Channel (Revenue, USD Billion)
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
By Region (Revenue, USD Billion)
North America
- U.S
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
For more information about this report visit https://www.researchandmarkets.com/r/t9yvns
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900